PDB 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry36 (41): 12526–34. PMID9376357. doi:10.1021/bi9712450.
Hoorn RK, Flickweert JP, Staal GE (1974). "Purification and properties of enolase of human erythroctyes". Int J Biochem5 (11–12): 845–52. doi:10.1016/0020-711X(74)90119-0.
Poyner RR, Laughlin LT, Sowa GA, Reed GH (1996). "Toward identification of acid/base catalysts in the active site of enolase: comparison of the properties of K345A, E168Q, and E211Q variants". Biochemistry35 (5): 1692–9. PMID8634301. doi:10.1021/bi952186y.
Wedekind JE, Reed GH, Rayment I (1995). "Octahedral coordination at the high-affinity metal site in enolase: crystallographic analysis of the MgII—enzyme complex from yeast at 1.9 Å resolution". Biochemistry34 (13): 4325–30. PMID7703246. doi:10.1021/bi00013a022.
Wedekind JE, Poyner RR, Reed GH, Rayment I (1994). "Chelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-Å resolution". Biochemistry33 (31): 9333–42. PMID8049235. doi:10.1021/bi00197a038.
Larsen TM, Wedekind JE, Rayment I, Reed GH (1996). "A carboxylate oxygen of the substrate bridges the magnesium ions at the active site of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruvate at 1.8 Å resolution". Biochemistry35 (14): 4349–58. PMID8605183. doi:10.1021/bi952859c.
Duquerroy S, Camus C, Janin J (1995). "X-ray structure and catalytic mechanism of lobster enolase". Biochemistry34 (39): 12513–23. PMID7547999. doi:10.1021/bi00039a005.
Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, Suzuki H, Kuriyama M (2005). "Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy". J. Neuroimmunol.162 (1–2): 130–6. PMID15833368. doi:10.1016/j.jneuroim.2005.02.004.
PDB 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry36 (41): 12526–34. PMID9376357. doi:10.1021/bi9712450.
Poyner RR, Laughlin LT, Sowa GA, Reed GH (1996). "Toward identification of acid/base catalysts in the active site of enolase: comparison of the properties of K345A, E168Q, and E211Q variants". Biochemistry35 (5): 1692–9. PMID8634301. doi:10.1021/bi952186y.
Wedekind JE, Reed GH, Rayment I (1995). "Octahedral coordination at the high-affinity metal site in enolase: crystallographic analysis of the MgII—enzyme complex from yeast at 1.9 Å resolution". Biochemistry34 (13): 4325–30. PMID7703246. doi:10.1021/bi00013a022.
Wedekind JE, Poyner RR, Reed GH, Rayment I (1994). "Chelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-Å resolution". Biochemistry33 (31): 9333–42. PMID8049235. doi:10.1021/bi00197a038.
Larsen TM, Wedekind JE, Rayment I, Reed GH (1996). "A carboxylate oxygen of the substrate bridges the magnesium ions at the active site of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruvate at 1.8 Å resolution". Biochemistry35 (14): 4349–58. PMID8605183. doi:10.1021/bi952859c.
Duquerroy S, Camus C, Janin J (1995). "X-ray structure and catalytic mechanism of lobster enolase". Biochemistry34 (39): 12513–23. PMID7547999. doi:10.1021/bi00039a005.
Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, Suzuki H, Kuriyama M (2005). "Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy". J. Neuroimmunol.162 (1–2): 130–6. PMID15833368. doi:10.1016/j.jneuroim.2005.02.004.
Centers for Disease Control and Prevention (CDC) (2002). "Populations receiving optimally fluoridated public drinking water—United States, 2000". MMWR Morb Mortal Wkly Rep.51 (7): 144–7. PMID11905481.
PDB 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry36 (41): 12526–34. PMID9376357. doi:10.1021/bi9712450.